E-LIB Suche - Ergebnisse für: Tong, Sandra

1

NGLY1 deficiency: a prospective natural history study:

Tong, Sandra ; Ventola, Pamela ; Frater, Christina H...
Human Molecular Genetics. 32 (2023) 18 - p. 2787-2796 , 2023

2

Fostamatinib for the treatment of warm antibody autoimmune ..:

Kuter, David J. ; Rogers, Kerry A. ; Boxer, Michael A....
American Journal of Hematology. 97 (2022) 6 - p. 691-699 , 2022

Link: https://doi.org/10.1002/..

3

NGLY1 deficiency: estimated incidence, clinical features, a..:

Stanclift, Caroline R. ; Dwight, Selina S. ; Lee, Kevin...
Orphanet Journal of Rare Diseases. 17 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

4

561. Phase 3 Trial of Fostamatinib for the Treatment of COV..:

Mallat, Ziad ; Lobo, Suzana Margareth ; Malik, Anuj.
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S382-S383 , 2021

Link: https://doi.org/10.1093/..

5

Fostamatinib is an effective second‐line therapy in patient..:

Boccia, Ralph ; Cooper, Nichola ; Ghanima, Waleed...
British Journal of Haematology. 190 (2020) 6 - p. 933-938 , 2020

Link: https://doi.org/10.1111/..

6

Long‐term fostamatinib treatment of adults with immune thro..:

Bussel, James B. ; Arnold, Donald M. ; Boxer, Michael A....
American Journal of Hematology. 94 (2019) 5 - p. 546-553 , 2019

Link: https://doi.org/10.1002/..

7

The measurement of physical functioning among patients with..:

Gelhorn, Heather L. ; Ye, Xin ; Speck, Rebecca M....
Journal of Patient-Reported Outcomes. 3 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

8

Patient-reported Symptoms of Tenosynovial Giant Cell Tumors:

Gelhorn, Heather L. ; Tong, Sandra ; McQuarrie, Kelly...
Clinical Therapeutics. 38 (2016) 4 - p. 778-793 , 2016

Link: https://doi.org/10.1016/..

9

Novel p38α Mitogen‐Activated Protein Kinase Inhibitor Shows..:

Tong, Sandra E. ; Daniels, Stephen E. ; Black, Peter...
The Journal of Clinical Pharmacology. 52 (2012) 5 - p. 717-728 , 2012

Link: https://doi.org/10.1177/..

10

Fostamatinib for the treatment of warm antibody autoimmune ..:

Kuter, David ; Rogers, Kerry ; Boxer, Michael...
qt5bb3c67f. , 2022

Link: https://escholarship.org..

11

NGLY1 deficiency: estimated incidence, clinical features, a..:

Stanclift, Caroline R ; Dwight, Selina S ; Lee, Kevin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759919/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Fostamatinib is an effective second-line therapy in patient..:

Boccia, Ralph ; Cooper, Nichola ; Ghanima, Waleed Khalid...
http://urn.nb.no/URN:NBN:no-84088. , 2020

Link: http://hdl.handle.net/10..

13

Long‐term fostamatinib treatment of adults with immune thro..:

Bussel, James B ; Arnold, Donald M ; Boxer, Michael A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594140/. , 2019

Link: http://www.ncbi.nlm.nih...

14

Patient-reported Symptoms of Tenosynovial Giant Cell Tumors:

Gelhorn, Heather L ; Tong, Sandra ; McQuarrie, Kelly...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469507/. , 2016

Link: http://www.ncbi.nlm.nih...

15

CSF1 Receptor Inhibition of Tenosynovial Giant Cell Tumor U..:

Peterfy, Charles ; Chen, Yan ; Countryman, Peter...
Future Oncology. 18 (2022) 12 - p. 1449-1459 , 2022

Link: https://doi.org/10.2217/..